Mindfulness to Mitigate the Effect of Anxiety-depression-fear in Chronic Obstructive Pulmonary Disease (COPD)



Status:Withdrawn
Conditions:Chronic Obstructive Pulmonary Disease, Depression, Pulmonary
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:40 - Any
Updated:12/30/2017
Start Date:April 2016
End Date:October 31, 2017

Use our guide to learn which trials are right for you!

Mindfulness to Mitigate the Effect of Anxiety-depression-fear in COPD

People with COPD have a greater risk for symptoms of depression, anxiety, and fear of
breathlessness. Those emotions are independently associated with lower physical activity,
poorer quality of life, and higher hospitalization and exacerbations; all independent
predictors of survival and costs. There is a lack of treatment options to be routinely used
in primary clinics for patients with COPD. Systematic reviews suggest that interventions that
promote an accepting mode of response, such as mindfulness, might be more appropriate and
effective for managing psychological distress in COPD patients, especially breathing-related
anxiety.

Hypothesis: A home-based 8-week Mindfulness-Based Stress Reduction (MBSR) for COPD targeted
to individuals with symptoms of depression, anxiety, or fear of breathlessness delivered by a
mindfulness coach using a combination of in-person sessions and remote video call sessions
will be effective in improving emotional and overall quality of life, and measured physical
activity.


Inclusion criteria:

- Lung disease diagnosis

- Demonstrated competence in proposed technology

- Current or past smoking status

- Patient Health Questionnaire-2 (PHQ-2) or Generalized Anxiety Disorder scale (GAD-2)
score >2 points or answering yes to a validated question of fear of being breathless
("Do you experience fear, or panic when you have difficulty getting your breath a good
bit of the time?")

Exclusion criteria:

- High likelihood of non-compliance or low confidence using the technology

- Patients currently in pulmonary rehabilitation

- Inability to walk

- Prescribed antidepressant or antianxiety medication within last month

- Documented substance abuse

- Cognitive impairment as defined by the Mini-Mental test score < 24.
We found this trial at
1
site
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials